Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Hepatic arterial infusion chemotherapy (HAIC) using the FOLFOX regimen has been explored for unresectable hepatocellular carcinoma (HCC) patients, yet predictive biomarkers are lacking. This study aimed to evaluate the potential of serum growth differentiation factor 15 (GDF15) as a biomarker for predicting therapeutic response and survival outcomes in HCC patients undergoing FOLFOX-HAIC.
Methods: Pretreatment serum samples were collected from patients with unresectable HCC who received FOLFOX-HAIC between October 2016 and January 2019. GDF15 levels were measured using enzyme-linked immunosorbent assay (ELISA). Associations between serum GDF15 levels and treatment response, overall survival (OS), progression-free survival (PFS), and clinical characteristics were analyzed.
Results: A total of 150 patients were included in the study. The mean GDF15 level was 7.16 ng/mL (mean ± SEM: 7.16 ± 0.72; range: 0.39-53.55 ng/mL). High serum GDF15 levels were significantly associated with poorer treatment response, shorter OS (median: 21.1 vs 40.33 months, = 0.0081) and PFS (median: 13.93 vs 20.47 months, = 0.0125). Multivariate Cox proportional hazards analysis identified serum GDF15 as an independent predictor of PFS (HR, 1.521; 95% CI, 1.014-2.283; = 0.043). Additionally, elevated GDF15 was positively correlated with larger tumor size ( < 0.0001), presence of microvascular invasion ( = 0.026) and abnormal AST levels ( = 0.001).
Conclusion: Serum GDF15 represents a potential prognostic biomarker in patients with unresectable HCC undergoing FOLFOX-HAIC treatment and may help guide treatment stratification.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12267266 | PMC |
| http://dx.doi.org/10.3389/fimmu.2025.1619387 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Regulation of food intake by Connexin43 via adipocyte-sensory neuron electrical synapses.
Mol Metab
September 2025
Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX, 77030, USA. Electronic address:
Background And Objective: Connexin43 (Cx43), encoded by Gja1, forms gap junctions between adjacent cells. In adipose tissue, it is upregulated during adipose beiging while downregulated by high-fat-diet (HFD) feeding. Adipocyte-specific Gja1 overexpression enhances adipose tissue beiging in response to mild cold stress of room temperature.
View Article and Find Full Text PDFA new characteristıc of systemic lupus erythematosus: subclinical vein involvement-an in-depth biochemical and imaging study.
Rheumatology (Oxford)
September 2025
Department of Rheumatology, Gazi University Faculty of Medicine, Ankara, Turkey.
Objectives: Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disorder often complicated by vascular events, with or without antiphospholipid antibody syndrome (APS). This study aimed to explore subclinical venous involvement in SLE using biochemical and imaging modalities, focusing on vein wall thickness (VWT) and inflammation-related biomarkers.
Methods: In this cross-sectional study, 68 SLE patients were categorized based on antiphospholipid antibody (APA) status and clinical APS.
Inflammatory pathways in vascular disease are the focus of intense interest. Accumulating evidence suggests a role for GDF-15 in the atherosclerotic process. In this study we measured circulating levels of IL-6 and GDF-15 in a cohort of 20 vascular surgical patients with atherosclerotic disease presenting for surgical revascularisation and in a similar number of age-matched healthy volunteers.
View Article and Find Full Text PDFSerum levels of GDF-15, betatrophin, TNF-α and IL-6 in diabetic patients with and without diabetic complications.
Saudi Med J
September 2025
From the Department of Family Medicine (Yılmaz), School of Medicine, Dicle University, Diyarbakir, Department of Molecular Biology and Genetics (Kaymaz), Faculty of Arts and Sciences, Nevşehir, Hacı Bektaş Veli University, Nevşehir, Department of Family Medicine (Yakar, Gömleksiz, Önalan, Gü
Objectives: To investigate serum levels of growth differentiation factor 15 (GDF-15), inflammatory biomarkers, and betatrophin in individuals with diabetes mellitus, both with and without complications.
Methods: A cross-sectional analysis was conducted involving patients with diabetes. Participants were categorized into 3 groups: Group 1 (30 healthy individuals without diabetes), Group 2 (30 diabetic patients without complications), and Group 3 (30 diabetic patients with complications).
A reduction in serum IFN-γ, IL-1β, IL-6, and GM-CSF serves as potential markers for a positive outcome to lumbar epidural steroid injections.
PLoS One
August 2025
Center of Excellence in Osteoarthritis and Musculoskeleton, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Introduction: This study evaluated serum inflammatory cytokine levels before and after transforaminal epidural steroid injections (TFESI) to assess their potential as biomarkers for predicting favorable outcomes in patients with lumbosacral radiculopathy.
Methods: All 120 eligible patients diagnosed with lumbosacral radiculopathy underwent blood collection 1) before TFESI and 2) two weeks after the procedure. A 5.